ReviewTranslational lung cancer research2015

Neoadjuvant and adjuvant epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy for lung cancer.

Haoran Zhai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.